The NIH has awarded Miro Health a $2.5M grant to support the commercialization of their automated neurological and psychiatric diagnostic and treatment monitoring services for healthcare delivery. Miro Health’s unique, mobile technologies allow patients to remotely self-administer assessments of neurological, cognitive, and psychiatric conditions. The company’s patented technologies support unmatched, symptom-based differential diagnosis and monitoring and has previously been designated a Breakthrough Device by the FDA (Software as a Medical Device).
top of page
Recent PostsSee All
Miro Health has been granted breakthrough device designation by the Food and Drug Administration (FDA) for its mobile, self-administered, neurobehavioral assessment technologies. FDA's Breakthrough De
Miro Health and Johns Hopkins have teamed up to investigate how COVID-19 affects the brain. Doctors on the frontlines of COVID-19 have been reporting unusual symptoms ranging from loss of smell and ne
The design of digital interactions that can elicit consistent responses is a good challenge for any UI/UX professional. Pair that with the need for exquisite precision and reproducibility regardless o
bottom of page